Aurobindo Pharma Limited — Important, 02-02-2026: Updates
02-02-2026 | 10:06 am
02-02-2026 | 10:06 am
Government imposed Minimum Import Price (MIP) on Penicillin-G and other pharma ingredients. Aurobindo's subsidiary, Lyfius Pharma, manufactures Penicillin-G, which could benefit from reduced import competition. The company stated recent share volume movement is market-driven, with no new specific info.
No comments yet. Be the first to comment!
